Evidence map›Paper›PMID 33796884›Full record

ArticleArchives of virology2021

Molecular surveillance of coxsackievirus A16 in southern China, 2008-2019.

Lina Yi, Hanri Zeng, Huanying Zheng, Jinju Peng, Xue Guo, Leng Liu, Qianling Xiong, Limei Sun, Xiaohua Tan, Jianfeng He and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lina Yi *Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangzhou, China.
Hanri Zeng *Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangzhou, China.
Huanying ZhengGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangzhou, China.
Jinju PengGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangzhou, China.
Xue GuoGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangzhou, China.
Leng LiuGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangzhou, China.
Qianling XiongGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangzhou, China.ORCID http://orcid.org/0000-0002-4882-0695
Limei SunGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangzhou, China.
Xiaohua TanGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangzhou, China.
Jianfeng HeGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangzhou, China.
Jing LuGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangzhou, China. Jimlu0331@163.com.
Hui LiGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, Guangzhou, China. gdcdclihui@163.com.

Funding

Guangdong Medical Research Foundation A2019408Science and Technology Planning Project of Guangdong 2018B020207006The Key Research and Development Program of Guangdong Province 2019B111103001
6 · The paper itself

Abstract

A national surveillance system on hand, foot, and mouth disease (HFMD) was launched in 2008 in China. Since then, millions of HFMD cases have been reported each year, with enterovirus A71 (EV-A71), coxsackievirus A16 (CV-A16), and coxsackievirus A6 (CV-A6) as the major causative pathogens. Long-term surveillance of viral infection rates and genetic changes is essential for understanding the disease epidemiology pattern. Here, we analyzed molecular surveillance data on CV-A16 covering a period of 12 years (2008-2019) in Guangdong, China, one of the regions reporting the largest number of HFMD cases. Full VP1 sequences of 456 strains were determined to examine the genetic diversity and changes in the distribution of CV-A16 variants. Our study revealed an irregular pattern of CV-A16 infections in Guangdong. Different from the cyclic epidemics observed in some Asia-Pacific regions, there was a continuously high CV-A16 infection rate from 2008 to 2014, and after a period of lower epidemic activity in 2015-2017, an upsurge of CV-A16 infection was observed in 2018-2019. Cocirculation of subgenotypes B1a and B1b was observed, but while subgenotype B1a was predominant from 2008 to 2012, it appears to have been replaced by B1b, which has circulated as the predominant subgenotype since 2013. Phylogenetic analysis showed that most of the circulating CV-A16 strains are endemic, with occasional transmission between neighboring regions. The re-emergence of B1a in 2016-2019 in Guangdong was likely the result of introduction(s) from Southeast Asia. These results highlight the importance of continuous molecular surveillance from different areas, which will improve our understanding of the origin of the epidemic and facilitate the development of strategies for HFMD disease control.

Indexed as

Enterovirus A, HumanChinaGenotypeHand, Foot and Mouth DiseaseHumansIncidenceMolecular EpidemiologyPhylogenyRetrospective Studies

Identifiers

PMID33796884

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.